Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000235106

Medchemexpress LLC MTI-31 | 1567915-38-1 | 100.0% | 474.55 | C26H30N6O3 | 1MG
SDP

Catalog No. 5000235106
Encompass_Preferred

MTI-31 (LXI-15029) is a potent, orally active, and highly selective inhibitor of mTORC1 and mTORC2 used in preclinical cancer research. It demonstrates strong biochemical potency and in vivo efficacy in tumor models, with formulation and storage guidance for laboratory use.

  • Potent, selective inhibition of mTORC1 and mTORC2.
  • High binding affinity for mTOR (Kd 0.20 nM) and low biochemical IC50 (39 nM).
  • High purity and consistent solid appearance for reproducible results.
  • Soluble in DMSO and compatible with common in vivo formulations.
  • Stable as powder at low temperatures and in solvent with recommended storage conditions.
  • Molecular formula C26H30N6O3 and molecular weight 474.55.

Catalog No. 50-002-35106 Supplier Medchemexpress LLC Supplier No. HY1260771MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

MTI-31 (LXI-15029) is a potent, orally active, and highly selective inhibitor of mTORC1 and mTORC2 used in preclinical cancer research. It demonstrates strong biochemical potency and in vivo efficacy in tumor models, with formulation and storage guidance for laboratory use.

  • Potent, selective inhibition of mTORC1 and mTORC2.
  • High binding affinity for mTOR (Kd 0.20 nM) and low biochemical IC50 (39 nM).
  • High purity and consistent solid appearance for reproducible results.
  • Soluble in DMSO and compatible with common in vivo formulations.
  • Stable as powder at low temperatures and in solvent with recommended storage conditions.
  • Molecular formula C26H30N6O3 and molecular weight 474.55.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.